KAT8 (MOF), FLAG-Tag Recombinant

KAT8 (MOF), FLAG-Tag Recombinant
Artikelnummer
BPS102167-1
Verpackungseinheit
20 µg
Hersteller
BPS Bioscience

Verfügbarkeit: wird geladen...
Preis wird geladen...
Products from BPS Bioscience require a minimum order value above 400€

Encompassing Amino Acids: 2-458(end)

Application: Useful for SDS-PAGE

Background: KAT8 (lysine acetyltransferase 8), also known as MOF, is a histone acetyltransferase which adds acetyl groups to histone H4 at lysine 16. KAT8 activity impacts chromatin regulation, DNA damage repair, cell differentiation, and apoptosis. KAT8 dysfunction can result in development and metastasis of AML (acute myeloid leukemia) and other cancer types. Small molecule KAT8 inhibitors have been developed in efforts to further the study of KAT8 function and its impact in cancer progression. KAT8 has also been identified as a risk gene for the development of PD (Parkinson’s disease), due to its role in Parkin-dependent mitophagy. Further studies will elucidate the exact role of this protein and how best to target it for therapeutic purposes.

Description: Recombinant human full-length KAT8 (lysine acetyltransferase 8), also known as MOF, encompassing amino acids 2-458(end). This construct contains a N-terminal FLAG-tag. The recombinant protein was affinity purified.

Format: Aqueous buffer solution

Formulation: 40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, 20% glycerol, and 100 µg/ml FLAG peptide

Genbank: NM_032188.3

Purity: ≥85%

Storage Stability: At least 6 months at -80°C.

Tags: FLAG

Target: KAT8

Uniprot: Q9H7Z6

Warnings: Avoid freeze/thaw cycles. Protein may be diluted to ≥ 100 μg/ml in PBS + glycerol and stored at -80°C.

Biosafety Level: Not applicable (BSL-1)
Mehr Informationen
Artikelnummer BPS102167-1
Hersteller BPS Bioscience
Hersteller Artikelnummer 102167-1
Verpackungseinheit 20 µg
Mengeneinheit STK
Wirt Human
Produktinformation (PDF) Download
MSDS (PDF)
×